{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:48:59Z","timestamp":1774345739742,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI152772"],"award-info":[{"award-number":["R01AI152772"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["32FP30_207285"],"award-info":[{"award-number":["32FP30_207285"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["324730_207957"],"award-info":[{"award-number":["324730_207957"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["P5R5PM_225275"],"award-info":[{"award-number":["P5R5PM_225275"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Integrase mutations associated with dolutegravir resistance have been well characterized, but based on limited data from non-B subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aim to identify potential integrase mutations not currently classified as integrase strand transfer inhibitor (INSTI) resistance mutations (DRMs) in individuals with viremia on dolutegravir-based regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included integrase sequences from DTG RESIST study sites in African countries. These were interpreted using Stanford HIVdb v9.8. We used a viral genome-wide association study-like approach restricted to the integrase region (INT-WAS) to identify mutations not classified as major or accessory INSTI DRMs but occurring more frequently in sequences carrying major INSTI DRMs than in those without major INSTI DRMs. We performed the same INT-WAS analysis with drug-na\u00efve sequences from the Los Alamos HIV-1 database to test whether these identified mutations were enriched among sequences from individuals with viraemia whilst receiving DTG-based treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 382 sequences, 104 (27.2%) showed at least intermediate dolutegravir resistance. Twelve integrase mutations not classified as major or accessory DRMs (S39R, L45I, I72L, L74I, V79I, I113V, S119R, K156N, I208M, T218M, A265V, and R284G) were significantly associated with predicted DTG resistance. Among them, V79I [adjusted odds ratio (aOR) 167.1, 95% credible interval (CrI) 17.9\u20132947.6] and I72L (aOR 65.6, 95% CrI 6.6\u20131273.7) were strongly associated. S39R, L45I, V79I, S119R, and K156N were linked to established INSTI resistance pathways, and I72L, L74I, V79I, K156N, I208M, and R284G were overrepresented in sequences from viraemic individuals on DTG-based treatment relative to drug-na\u00efve sequences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified several amino acid substitutions outside the established DRMs that are strongly associated with predicted dolutegravir resistance. Dolutegravir resistance evolution is complex and likely involves mutations not currently classified as DRMs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag088","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:11:53Z","timestamp":1774332713000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study"],"prefix":"10.1093","volume":"81","author":[{"given":"Nuri","family":"Han","sequence":"first","affiliation":[{"name":"of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich Department , University of Zurich, Zurich ,","place":["Switzerland"]},{"name":"Institute of Medical Virology, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-3562","authenticated-orcid":false,"given":"Tom","family":"Loosli","sequence":"additional","affiliation":[{"name":"of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich Department , University of Zurich, Zurich ,","place":["Switzerland"]},{"name":"Institute of Medical Virology, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamatha","family":"Sauermann","sequence":"additional","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-6463","authenticated-orcid":false,"given":"\u0130pek","family":"\u00c7elika\u011f","sequence":"additional","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanina","family":"Anderegg","sequence":"additional","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertha C","family":"Baye","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal , Durban ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Bolton Moore","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia , Lusaka ,","place":["Zambia"]},{"name":"School of Medicine, University of Alabama at Birmingham , Birmingham, AL ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Buzaalirwa","sequence":"additional","affiliation":[{"name":"AIDS Healthcare Foundation Uganda Cares Medical Department, , Masaka ,","place":["Uganda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-1564","authenticated-orcid":false,"given":"Helen","family":"Byakwaga","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology , Mbarara ,","place":["Uganda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-3523","authenticated-orcid":false,"given":"Cleophas","family":"Chimbetete","sequence":"additional","affiliation":[{"name":"Newlands Clinic Research and Training Unit, , Harare ,","place":["Zimbabwe"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter V","family":"Ebasone","sequence":"additional","affiliation":[{"name":"Clinical Research Education Networking and Consultancy (CRENC) Department of Communicable Diseases, , Yaound\u00e9, Centre Region ,","place":["Cameroon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Goodrich","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Indiana University School of Medicine , Indianapolis, IN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8786-2487","authenticated-orcid":false,"given":"Jacqueline","family":"Huwa","sequence":"additional","affiliation":[{"name":"Lighthouse Trust , Lilongwe ,","place":["Malawi"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Kasozi","sequence":"additional","affiliation":[{"name":"Public Health Department, Regional Referral Hospital , Masaka ,","place":["Uganda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolphe","family":"Mafoua","sequence":"additional","affiliation":[{"name":"Centre de Traitement Ambulatoire , Pointe Noire ,","place":["Republic of the Congo"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcel Christ","family":"Massamba","sequence":"additional","affiliation":[{"name":"Centre de Traitement Ambulatoire , Brazzaville ,","place":["Republic of the Congo"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8ne","family":"Messou","sequence":"additional","affiliation":[{"name":"Centre de Prise en Charge, de Recherche et de Formation , Abidjan , C\u00f4te d'Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-6902","authenticated-orcid":false,"given":"Albert","family":"Minga","sequence":"additional","affiliation":[{"name":"Programme PAC-CI , Abidjan , C\u00f4te d'Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-5522","authenticated-orcid":false,"given":"Gad","family":"Murenzi","sequence":"additional","affiliation":[{"name":"Department of Research, Goodlife Access and Research for Development, Kigali ,","place":["Rwanda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Muula","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia , Lusaka ,","place":["Zambia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-2645","authenticated-orcid":false,"given":"Winnie","family":"Muyindike","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology , Mbarara ,","place":["Uganda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirelle J","family":"Naidoo","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal , Durban ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique Mahambou","family":"Nsonde","sequence":"additional","affiliation":[{"name":"Centre de Traitement Ambulatoire , Brazzaville ,","place":["Republic of the Congo"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-9179","authenticated-orcid":false,"given":"Armel G","family":"Poda","sequence":"additional","affiliation":[{"name":"Equipe de Recherche Clinique, Laboratoire des Pathog\u00e8nes Emergents et Re\u00e9mergents, Universit\u00e9 Nazi BONI , Bobo- Dioulasso ,","place":["Burkina Faso"]},{"name":"Service des Maladies Infectieuses, H\u00f4pital de Jour, Centre Hospitalier Universitaire Sour\u00f4 SANOU , Bobo-Dioulasso ,","place":["Burkina Faso"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Ramd\u00e9","sequence":"additional","affiliation":[{"name":"Souro Sanou University Hospital Department of Infectious Diseases, , Bobo-Dioulasso ,","place":["Burkina Faso"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aggrey","family":"Semeere","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, Makerere University , Kampala ,","place":["Uganda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Singh","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal , Durban ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-6723","authenticated-orcid":false,"given":"Huldrych F","family":"G\u00fcnthard","sequence":"additional","affiliation":[{"name":"of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich Department , University of Zurich, Zurich ,","place":["Switzerland"]},{"name":"Institute of Medical Virology, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7462-5132","authenticated-orcid":false,"given":"Matthias","family":"Egger","sequence":"additional","affiliation":[{"name":"of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich Department , University of Zurich, Zurich ,","place":["Switzerland"]},{"name":"Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town , Cape Town ,","place":["South Africa"]},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol , Bristol ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Giandhari","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal , Durban ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0926-710X","authenticated-orcid":false,"given":"Richard","family":"Lessells","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal , Durban ,","place":["South Africa"]},{"name":"Centre for the AIDS Programme of Research in South Africa , Durban ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger D","family":"Kouyos","sequence":"additional","affiliation":[{"name":"of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich Department , University of Zurich, Zurich ,","place":["Switzerland"]},{"name":"Institute of Medical Virology, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026032402114588400_dkag088-B1","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1016\/S2352-3018(20)30238-1","article-title":"Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon","volume":"7","author":"Calmy","year":"2020","journal-title":"Lancet HIV"},{"key":"2026032402114588400_dkag088-B2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"key":"2026032402114588400_dkag088-B3","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1016\/S2352-3018(22)00044-3","article-title":"Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I\/II open-label trial","volume":"9","author":"Ruel","year":"2022","journal-title":"Lancet HIV"},{"key":"2026032402114588400_dkag088-B4","first-page":"56","article-title":"Genetic barrier to resistance for dolutegravir","volume":"17","author":"Llibre","year":"2015","journal-title":"AIDS Rev"},{"key":"2026032402114588400_dkag088-B5","author":"World Health Organization"},{"key":"2026032402114588400_dkag088-B6","author":"World Health Organization"},{"key":"2026032402114588400_dkag088-B7","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1016\/S2352-3018(23)00228-X","article-title":"HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis","volume":"10","author":"Loosli","year":"2023","journal-title":"Lancet HIV"},{"key":"2026032402114588400_dkag088-B8","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1093\/cid\/ciaf204","article-title":"Drug resistance in people with viremia on dolutegravir-based antiretroviral therapy in Sub-Saharan Africa: the DTG RESIST study","volume":"81","author":"Loosli","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026032402114588400_dkag088-B9","author":"World Health Organization"},{"key":"2026032402114588400_dkag088-B10","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/v15091882","article-title":"Low prevalence of pre-treatment and acquired drug resistance to dolutegravir among treatment naive individuals initiating on tenofovir, lamivudine and dolutegravir in Zimbabwe","volume":"15","author":"Kouamou","year":"2023","journal-title":"Viruses"},{"key":"2026032402114588400_dkag088-B11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/cid\/ciae185","article-title":"Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho","volume":"79","author":"Tschumi","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026032402114588400_dkag088-B12","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/v15091932","article-title":"Treatment emergent dolutegravir resistance mutations in individuals na\u00efve to HIV-1 integrase inhibitors: a rapid scoping review","volume":"15","author":"Tao","year":"2023","journal-title":"Viruses"},{"issue":"Suppl 1","key":"2026032402114588400_dkag088-B13","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and uses of a public HIV drug-resistance database","volume":"194","author":"Shafer","year":"2006","journal-title":"J Infect Dis"},{"key":"2026032402114588400_dkag088-B14","first-page":"457","article-title":"2025 update of the drug resistance mutations in HIV-1","volume":"33","author":"Wensing","year":"2025","journal-title":"Top Antivir Med"},{"key":"2026032402114588400_dkag088-B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jgar.2025.04.002","article-title":"Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-na\u00efve individuals initiating second-generation integrase inhibitors","volume":"43","author":"Armenia","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"2026032402114588400_dkag088-B16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/jac\/dkx529","article-title":"Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance","volume":"73","author":"Malet","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026032402114588400_dkag088-B17","doi-asserted-by":"publisher","first-page":"e2134","DOI":"10.1093\/cid\/ciaa1614","article-title":"Predictors of virological failure and time to viral suppression of first-line integrase inhibitor\u2013based antiretroviral treatment","volume":"73","author":"Pyngottu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026032402114588400_dkag088-B18","doi-asserted-by":"publisher","first-page":"e085819","DOI":"10.1136\/bmjopen-2024-085819","article-title":"HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)","volume":"14","author":"Egger","year":"2024","journal-title":"BMJ Open"},{"key":"2026032402114588400_dkag088-B19","doi-asserted-by":"publisher","first-page":"e035246","DOI":"10.1136\/bmjopen-2019-035246","article-title":"International epidemiology databases to evaluate AIDS (IeDEA) in Sub-Saharan Africa, 2012\u20132019","volume":"10","author":"Chammartin","year":"2020","journal-title":"BMJ Open"},{"key":"2026032402114588400_dkag088-B20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"Pineda-Pe\u00f1a","year":"2013","journal-title":"Infect Genet Evol"},{"key":"2026032402114588400_dkag088-B21","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/nar\/gku739","article-title":"COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification","volume":"42","author":"Struck","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2026032402114588400_dkag088-B22","doi-asserted-by":"publisher","first-page":"e0163746","DOI":"10.1371\/journal.pone.0163746","article-title":"Genome-wide association study of HIV whole genome sequences validated using drug resistance","volume":"11","author":"Power","year":"2016","journal-title":"PLoS One"},{"key":"2026032402114588400_dkag088-B23","doi-asserted-by":"publisher","first-page":"e1010184","DOI":"10.1371\/journal.pcbi.1010184","article-title":"AC-PCoA: adjustment for confounding factors using principal coordinate analysis","volume":"18","author":"Wang","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"2026032402114588400_dkag088-B24","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1002\/sim.6605","article-title":"A guide to genome-wide association analysis and post-analytic interrogation","volume":"34","author":"Reed","year":"2015","journal-title":"Stat Med"},{"key":"2026032402114588400_dkag088-B25","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/sim.7273","article-title":"Firth\u2019s logistic regression with rare events: accurate effect estimates and predictions?","volume":"36","author":"Puhr","year":"2017","journal-title":"Stat Med"},{"key":"2026032402114588400_dkag088-B26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2026032402114588400_dkag088-B27","author":"Los Alamos HIV databases"},{"key":"2026032402114588400_dkag088-B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v014.i12","article-title":"A CLUE for CLUster ensembles","volume":"14","author":"Hornik","year":"2005","journal-title":"J Stat Soft"},{"key":"2026032402114588400_dkag088-B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Soft"},{"key":"2026032402114588400_dkag088-B30","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/jmv.25564","article-title":"Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-na\u00efve individuals","volume":"91","author":"Margot","year":"2019","journal-title":"J Med Virol"},{"key":"2026032402114588400_dkag088-B31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/jac\/dkp423","article-title":"Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection","volume":"65","author":"Garrido","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2026032402114588400_dkag088-B32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/infdis\/jiw165","article-title":"Successful prevention of transmission of integrase resistance in the Swiss HIV cohort study","volume":"214","author":"Scherrer","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag088\/67493019\/dkag088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag088\/67493019\/dkag088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:11:56Z","timestamp":1774332716000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag088\/8539050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag088","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,4]]},"article-number":"dkag088"}}